Blue Owl Capital presents a high-yield opportunity with a nearly 10% dividend despite concerns about its credit business. IBM receives a bullish catalyst as the US government proposes a $1 billion equity stake to support its quantum computing roadmap, highlighting strong growth potential in this emerging market. Additionally, Quantum Computing is viewed as a speculative buy due to its strong cash position and accelerating revenue in a market expected to grow at a 35% CAGR. Hims & Hers Health is rated Strong Buy, driven by its partnership with Novo Nordisk, international expansion, and focus on platform-driven healthcare growth.
IBM's business model remains strong despite a 7% decline in mainframe infrastructure revenue, supported by loyal legacy customers and solid free cash flow. Software growth, especially an 11% increase in Red Hat revenue, helps offset mainframe challen...
Energy prices cooled in June, easing inflation pressures despite ongoing tensions between the U.S. and Iran near the Strait of Hormuz. Morgan Stanley reported record quarterly revenue and profit, boosted by a surge in equities trading fueled by the A...
IBM reported earnings and revenue below expectations due to enterprises reducing spending on traditional IT systems to invest in their own AI infrastructure. This shift indicates companies prefer developing on-premises AI solutions with cheaper open-...
US stock futures rose after a softer-than-expected Consumer Price Index (CPI) report reduced the chances of a Federal Reserve rate hike in July. The market now awaits today's Producer Price Index (PPI) data, which could either confirm easing inflatio...
IBM introduced Power Autonomous Operations, an AI agent that autonomously monitors and resolves issues in Power systems up to 15 times faster than manual methods, enhancing system uptime and efficiency. Alongside, IBM launched the Power S1112, a comp...
